Impact of Payor-Initiated Switching of Inhaled Corticosteroids on Lung Function
- 9 March 2021
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 234, 128-133.e1
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Effect of Inhaler Design Variables on Paediatric Use of Dry Powder InhalersPLOS ONE, 2014
- The Utility of Forced Expiratory Flow between 25% and 75% of Vital Capacity in Predicting Childhood Asthma Morbidity and SeverityJournal of Asthma, 2012
- Forced expiratory flow between 25% and 75% of vital capacity and FEV1/forced vital capacity ratio in relation to clinical and physiological parameters in asthmatic children with normal FEV1 valuesJournal of Allergy and Clinical Immunology, 2010
- Inhaled corticosteroids for asthma: impact of practice level device switching on asthma controlBMC Pulmonary Medicine, 2009
- Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma–Summary Report 2007Journal of Allergy and Clinical Immunology, 2007
- Inhaled Corticosteroids in Children with AsthmaPediatric Drugs, 2007
- Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthmaEuropean Respiratory Journal, 2006
- High lung deposition of 99mTc-labeled ciclesonide administered via HFA-MDI to patients with asthmaRespiratory Medicine, 2006
- Ability of preschool children to use dry powder inhalers as evaluated by In‐Check MeterPediatrics International, 2006
- Low-Dose Inhaled Corticosteroids and the Prevention of Death from AsthmaNew England Journal of Medicine, 2000